U.S. Markets closed
  • S&P 500

    3,310.11
    +39.08 (+1.19%)
     
  • Dow 30

    26,659.11
    +139.16 (+0.52%)
     
  • Nasdaq

    11,185.59
    +180.72 (+1.64%)
     
  • Russell 2000

    1,561.58
    +18.30 (+1.19%)
     
  • Crude Oil

    36.14
    -0.03 (-0.08%)
     
  • Gold

    1,868.40
    +0.40 (+0.02%)
     
  • Silver

    23.39
    +0.02 (+0.11%)
     
  • EUR/USD

    1.1680
    -0.0070 (-0.5956%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2931
    -0.0056 (-0.4306%)
     
  • USD/JPY

    104.5410
    +0.2400 (+0.2301%)
     
  • BTC-USD

    13,461.53
    -81.38 (-0.60%)
     
  • CMC Crypto 200

    264.05
    +21.37 (+8.80%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,331.94
    -86.57 (-0.37%)
     

Allscripts Closes Previously Announced Sale of EPSi

·1 min read

Allscripts (NASDAQ: MDRX) closed the previously announced sale of EPSi to Strata Decision Technology on October 15 for $365 million. EPSi is a leading provider of financial decision support and planning tools for hospitals and health systems.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201015005291/en/

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com